Here's from The Economist this morning:
"Venture-capital funds based in China poured $1.4bn into private American biotech firms in the first three months of 2018, about 40% of the total."In essence, when it's in your immediate, your family's, your local community's, your savings account's or your investment portfolio's best interest to purchase a product from China (i.e., you have more money to spend/save/invest when you shop the world for price), know that you may also be providing the capital that could ultimately save lives. No kidding!
No comments:
Post a Comment